BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meseci E, Naki MM. Prognostic factors, survival outcomes, and surgical practices when dealing with uterine sarcomas: 8 years’ clinical experience. J Turk Ger Gynecol Assoc 2019;20:154-64. [PMID: 31298514 DOI: 10.4274/jtgga.galenos.2019.2019.0061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Suchetha S, Vijayashanti T, Rema P, Sivaranjith J, kumar A, Krishna KMJ, James FV. Uterine Sarcoma: Retrospective Study From A Single institute. J Obstet Gynecol India. [DOI: 10.1007/s13224-021-01612-9] [Reference Citation Analysis]
2 Pezzicoli G, Moscaritolo F, Silvestris E, Silvestris F, Cormio G, Porta C, D'Oronzo S. Uterine carcinosarcoma: An overview. Crit Rev Oncol Hematol 2021;163:103369. [PMID: 34051304 DOI: 10.1016/j.critrevonc.2021.103369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Jeong MJ, Park JH, Hur SY, Kim CJ, Nam HS, Lee YS. Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in Uterine Sarcoma. J Clin Med 2020;9:E2898. [PMID: 32911724 DOI: 10.3390/jcm9092898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]